跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 254,668 条关于
“NAD Pharmaceuticals Corp.”
全部
254,668
临床试验
234,970
药物
3,269
机构
3,001
资讯
13,428
2个月前
Niagen Bioscience Launches NB4168, a Proprietary NAD+ Precursor, as First Pharmaceutical Candidate for Ataxia Telangiectasia
去年
Tonix Pharmaceuticals Bolsters Leadership Team and Provides Update on TNX-102 SL
3个月前
Gundry MD Launches Elevate NAD+: NMN Supplement with Patent-Pending Beadlet Technology Targets Age-Related NAD+ Decline
8个月前
Niagen Bioscience Acquires Core NAD+ Patent Portfolio from Queen's University Belfast
4年前
ChromaDex Strengthens Patent Portfolio with Two New Continuation Patents for Nicotinamide Riboside Manufacturing
24天前
NAD+ Precursor Supplements May Undermine Pancreatic Cancer Chemotherapy, Study Warns
8个月前
Researchers Achieve Complete Alzheimer's Reversal in Mouse Models Through NAD+ Restoration
去年
BriaCell Therapeutics Reports Progress in Phase 3 Metastatic Breast Cancer Trial
去年
BriaCell's Bria-IMT™ Shows Promise in Metastatic Breast Cancer Phase 2 Trial
10个月前
NAD+ Supplement Shows Early Promise for Long COVID Fatigue and Brain Fog in Clinical Trial
第 1 页,共 1343 页
上一页
下一页